Osteogenesis imperfecta and malignant hyperthermia. Is there a relationship?

Anaesthesia

Volumn 51, Issue 9, 1996, Pages 863-865

  Ørding, Helle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Anaesthetics; intravenous; Complications; osteogenesis imperfecta; Hyperthermia; malignant

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; FENTANYL; NITROUS OXIDE; PANCURONIUM;

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; HYPERMETABOLISM; MALE; MALIGNANT HYPERTHERMIA; METABOLIC ACIDOSIS; OSTEOGENESIS IMPERFECTA; RESPIRATORY ACIDOSIS; SCHOOL CHILD; TACHYCARDIA;

EID: 9544239431     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1996.tb12619.x     Document Type: Article

References (11)

1. BYERS PH. Osteogenesis imperfecta. In: ROYCE PM. STEINMANN B, eds. Connectire tissue and its heritable disorders. Molecular, genetic and medical aspects. New York: Wiley-Liss. 1993: 317-50.
2. SILLENCE DO, SENN A, DANKS DM. Genetic heterogeneity in osteogenesis imperfecta. Journal of Medical Genetics 1979; 16: 101-16.
3. CROPP GJA, MYERS DN. Physiological evidence of hypermetabolism in osteogenesis imperfecta. Pediatrics 1972; 49: 375-91.
4. RVAN CA, AL-GHAMDI AS, GAYLE M, FINER NN. Osteogenesis imperfecta and hyperthermia. Anesthesia and Analgesia 1989; 68: 811-4.
5. RAMPTON AJ, KELLY DA, SHANAHAN EC, INGRAM GS. Occurrence of malignant hyperpyrexia in a patient with osteogenesis impcrfecta. British Journal of Anaesthesia 1984; 56: 1443-6.
6. MASUDA Y, HARADA Y, HONMA E, ICHIMIYA T, NAMIKI A. Anesthetic management of a patient with osteogenesis imperfecta cungentia. Masui 1990; 39: 383-7.
7. SADAT-ALI M, SANKARAN-KUTTY M, ADU-GYAMFI Y. Metabolic acidosis in osteogenesis imperfecta European Journal of Pediatrics 1986; 145: 582-3.
8. ØRDING H, BENDIXEN D. Malign hypertermi. Nordisk Medicin 1992; 107: 12-4.
9. QUANE KA, KEATING KE, MANNING BM, HEALY JMS. MONSIEURS K, HEFFRON JJA, LEHANE M, HEYTENS L, KRIVOSIC-HORBER R, ADNET P, ELLIS FR, MONMIR N, LUNVRDI J, MCCARTHY TV. Detection of a novel common mutation in the ryanodine receptor gene in malignant hypertliermia. Human Molecular Genetics 1994; 3: 471-6.
10. ØRDING H. Investigation of malignant hyperthermia susecptibility in Denmark. [Thesis.] Copenhagen: Laegeforeningens Forlag. 1995.
11. European MH Group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. British Journal of Anaesthesia 1984; 56: 1267-9.